5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione, 97.0%, 100mg

METHYL 4-PYRIDYLACETATE HCL, 97.0%, 100mg

Gluconic acid sodium salt, min. 99%, for synthesis, 500 g, plastic packaging.

tert-Butyl (1R,3S,5S)-8-azabicyclo[3.2.1]octan-3-ylcarbamate, 95.0%, 1g

N-(4-Hydroxycyclohexyl)acetamide, 95.0%, 5g

(R)-2-((tert-Butoxycarbonyl)amino)-3-(pyridin-4-yl)propanoic acid, 95.0%, 1g

2-Amino-3-ethylpentan-3-ol, 95%, 1g

1-(2-Chloro-3-hydroxyphenyl)ethan-1-one, 100mg

1-(3,4-Dihydro-2H-1,4-benzoxazin-2-yl)methanamine, 97.0%, 5g

(S)-2-((tert-butoxycarbonyl)amino)-3-(3-chloro-4-hydroxyphenyl)propanoic acid, 98%, 5g

[2-(4-methyl-5,6,7,8-tetrahydro-2-quinazolinyl)ethyl]amine dihydrochloride, 95.0%, 1g

4-Iodo-phenylalanine, 96%, 25g

(2-methyl-1-benzofuran-7-yl)amine hydrochloride, 95.0%, 10g